Transradial Access for High-Risk Percutaneous Coronary Intervention: Implications of the Risk-Treatment Paradox

Author:

Amin Amit P.12ORCID,Rao Sunil V.3ORCID,Seto Arnold H.4,Thangam Manoj12,Bach Richard G.12ORCID,Pancholy Samir5ORCID,Gilchrist Ian C.6ORCID,Kaul Prashant7ORCID,Shah Binita8ORCID,Cohen Mauricio G.9ORCID,Gluckman Ty J.10ORCID,Bortnick Anna11,DeVries James T.12ORCID,Kulkarni Hemant13ORCID,Masoudi Frederick A.14ORCID

Affiliation:

1. Cardiovascular Division, Washington University School of Medicine, St. Louis, MO (A.P.A., M.T., R.G.B.).

2. Barnes-Jewish Hospital, St. Louis, MO (A.P.A., M.T., R.G.B.).

3. The Duke Clinical Research Institute, Durham, NC (S.V.R.).

4. Tibor Rubin Veterans Affairs Medical Center, Long Beach, CA (A.H.S.).

5. Department of Cardiology, Mercy Hospital and Community Medical Center, Scranton, PA (S.P.).

6. Penn State University, College of Medicine, M.S. Hershey Medical Center, Hershey, PA (I.C.G.).

7. Piedmont Heart Institute, Atlanta, GA (P.K.).

8. Department of Medicine (Cardiology), VA New York Harbor Healthcare System and New York University School of Medicine (B.S.).

9. Cardiovascular Division, Department of Medicine, University of Miami Miller School of Medicine, FL (M.G.C.).

10. Center for Cardiovascular Analytics, Research and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR (T.J.G.).

11. Albert Einstein College of Medicine, Montefiore Medical Center, NY (A.B.).

12. Department of Medicine, Section of Cardiology, Dartmouth-Hitchcock Medical Center, Geisel School of Medicine, Lebanon NH (J.T.D.).

13. M&H Research, LLC San Antonio, TX (H.K.).

14. Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus Aurora, CO (F.A.M.).

Abstract

Background: Transradial percutaneous coronary intervention (PCI; TRI) reduces adverse outcomes when compared with transfemoral PCI (TFI). However, TRI is also used less in high-risk patients. It remains unknown how baseline patient risk influences access-site choice among PCI operators and whether the absolute benefit of TRI is greater among patients at high risk for bleeding, acute kidney injury (AKI), and death. Methods: We analyzed 28 005 PCIs performed in a 7-hospital system between July, 01, 2009 and April 30, 2018, to assess the choice of access-site (TRI versus TFI) as a function of baseline risk for bleeding, AKI, and death, and examined whether the association between TRI use (versus TFI) and in-hospital outcomes is influenced by baseline risk. Results: Among 28 005 PCIs, over a 9-year period, TRI increased over time, however, a risk-treatment paradox for TRI use was observed not only for bleeding risk, but also AKI, and mortality risks, where TRI use was lower in those at highest risk. Operator variability with TRI was large. The incidences of bleeding, AKI, and death were higher with TFI versus TRI. The absolute risk difference between TRI and TFI increased with increasing baseline risk. The number needed to treat to prevent one adverse event with TRI (versus TFI) in low-, moderate- and high-risk groups, respectively, was 259, 82, and 32 for bleeding; 194, 53, and 40 for AKI; and 957, 78, and 18 for death. Conclusions: This analysis of a large multicenter cohort of patients with PCI demonstrates a risk-treatment paradox for TRI use, not only for bleeding, but also for AKI and death. Despite this, a greater absolute risk difference favoring TRI was observed among patients with the highest baseline risk. Addressing the risk-treatment paradox by preferentially selecting TRI across the spectrum of risk, but especially high-risk cases, may be an important potential strategy for improving outcomes with PCI.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3